Initial results of NRG-LU001 indicate that, although the diabetes agent metformin was well-tolerated by patients, the agent has not clearly improved progression-free survival (PFS) or overall survival (OS) for trial participants with locally advanced non-small cell lung cancer (NSCLC). These results are based on local center reported outcomes. Trial participants will continue to be followed for changes in their status. The initial report of these results were presented at the American Society of Clinical Oncology (ASCO) Annual Meeting and the abstract was awarded a "Best of ASCO" designation.
* This article was originally published here
Sunday, 2 June 2019
A new way to predict complications after larynx cancer surgery
A technique that illuminates blood flow during surgery predicted which head and neck cancer patients were likely to have issues with wound healing. It could enable surgeons to make adjustments during surgery or recovery to improve outcomes.
* This article was originally published here
* This article was originally published here
North Korea swine flu outbreak puts South on edge
South Korean troops stationed along the world's last Cold War frontier have been put on high alert in the face of a new infiltration threat from the nuclear-armed North—fever-stricken wild boar.
* This article was originally published here
* This article was originally published here
Can cannabinoids help treat obsessive-compulsive disorder?
The body's endocannabinoid system, due to the critical role it plays in regulating neurotransmitter signaling, is an enticing target for drug development against disorders associated with anxiety, stress, and repetitive behaviors, such as obsessive-compulsive disorder (OCD). A comprehensive new review article that provides an overview of this complex system, endogenous and exogenous cannabinoids, results of animal studies and human trials to date, and recommendations for future directions is published in Cannabis and Cannabinoid Research.
* This article was originally published here
* This article was originally published here
Anesthesia works in Antarctica
New research presented at this year's Euroanaesthesia congress (the annual meeting of the European Society of Anaesthesiology) in Vienna, Austria (1-3 June) shows that commonly used anaesthetic drugs still work, even after exposure to the extreme environmental conditions of the Antarctic. The study was conducted by Professor Major Ricardo Navarro-Suay of Hospital Central de la Defensa "Gómez Ulla", Madrid, Spain (who serves in the Spanish Armed Forces) and colleagues.
* This article was originally published here
* This article was originally published here
App Store in crosshairs as Apple courts developers
Apple is set to court software savants at its annual developers conference beginning Monday while contending with criticism that the iPhone maker has made its App Store a walled garden.
* This article was originally published here
* This article was originally published here
Subscribe to:
Posts (Atom)